Indian markets hit fresh all-time highs as improving earnings, GST cuts, and easing macro pressures boost investor confidence. Quantum Advisors’ Nilesh Shetty says the worst of earnings downgrades is over, with banks, IT and insurance offering strong value. Industrial and FMCG stocks may lag, while an India–US tariff deal could trigger the next big market...Read More

In the Nifty500 pack, 10 stocks saw their closing prices fall below their 200-day moving average (200 DMA) on November 27, according to technical scan data from StockEdge.Read More

Vidya Wires is launching its Rs 300-crore IPO on December 3 with a price band of Rs 48–52. The issue includes fresh shares and an OFS, valuing the firm at a discount to industry peers. With strong FY25 revenues and solid profitability, the IPO offers attractive sector-linked growth potential.Read More

Indian stocks opened slightly higher on Friday, with both the Sensex and Nifty hovering near their all-time highs. Investors are anticipating interest-rate cuts in the U.S. and India, while also looking forward to resilient quarterly growth data driven by strong domestic demand.Read More

A 5-year swing high marks the highest price a stock has reached in the past five years and often acts as a significant resistance level.Read More

Emcure Pharmaceuticals’ shares could see action following a Goods and Services Tax search at its Mumbai offices. The inspection concluded this week. The company recently reported a robust rise in revenue and profit after tax. Domestic and international businesses both showed strong performance.Read More

Indian government bonds are poised for a flat to slightly lower opening as traders anticipate a significant debt auction today, followed by crucial economic growth figures. The benchmark 10-year yield is expected to trade within a narrow band.Read More

Zydus Lifesciences is set to be in focus after it received tentative approval from the United States Food and Drug Administration for Empagliflozin and Linagliptin combination tablets for type 2 diabetes, alongside final approval for a blood pressure treatment drug. The company also entered into a licensing and commercialisation pact with RK Pharma for a...Read More

Indian finance firms are actively seeking long-term funding. They anticipate the current rate-easing cycle will soon conclude. This makes it an ideal moment to issue longer-tenure bonds. Companies are aiming to lock in funds before borrowing costs potentially rise. This strategic move also helps meet year-end regulatory and investment needs.Read More

Japanese government bond yields climbed Friday as the government plans to issue more debt to fund substantial new spending. The 10-year JGB yield rose, heading for its steepest monthly increase in six months. Primary dealers suggested increasing issuance of shorter-term bonds while reducing super-long-dated debt.Read More